Challenges and possible solutions to colorectal cancer screening for the underserved
- PMID: 24681602
- PMCID: PMC3982886
- DOI: 10.1093/jnci/dju032
Challenges and possible solutions to colorectal cancer screening for the underserved
Abstract
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. CRC incidence and mortality can be reduced through screening. However, in the United States, screening participation remains suboptimal, particularly among underserved populations such as the uninsured, recent immigrants, and racial/ethnic minority groups. Increasing screening rates among underserved populations will reduce the US burden of CRC. In this commentary focusing on underserved populations, we highlight the public health impact of CRC screening, list key challenges to screening the underserved, and review promising approaches to boost screening rates. We identify four key policy and research priorities to increase screening among underserved populations: 1) actively promote the message, "the best test is the one that gets done"; 2) develop and implement methods to identify unscreened individuals within underserved population groups for screening interventions; 3) develop and implement approaches for organized screening delivery; and 4) fund and enhance programs and policies that provide access to screening, diagnostic follow-up, and CRC treatment for underserved populations. This commentary represents the consensus of a diverse group of experts in cancer control and prevention, epidemiology, gastroenterology, and primary care from across the country who formed the Coalition to Boost Screening among the Underserved in the United States. The group was organized and held its first annual working group meeting in conjunction with the World Endoscopy Organization's annual Colorectal Cancer Screening Committee meeting during Digestive Disease Week 2012 in San Diego, California.
Figures
Comment on
- doi: 10.1093/jnci/dju075
Similar articles
-
How can we boost colorectal and hepatocellular cancer screening among underserved populations?Curr Gastroenterol Rep. 2015 Jun;17(6):22. doi: 10.1007/s11894-015-0445-1. Curr Gastroenterol Rep. 2015. PMID: 26031831 Free PMC article.
-
Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.JAMA Intern Med. 2013 Oct 14;173(18):1725-32. doi: 10.1001/jamainternmed.2013.9294. JAMA Intern Med. 2013. PMID: 23921906 Free PMC article. Clinical Trial.
-
Colorectal cancer control: providing adequate care to those who need it.J Natl Cancer Inst. 2014 Apr;106(4):dju075. doi: 10.1093/jnci/dju075. Epub 2014 Mar 28. J Natl Cancer Inst. 2014. PMID: 24681601 No abstract available.
-
Evidence for colorectal cancer screening.Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833346 Review.
-
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.Can J Gastroenterol Hepatol. 2016;2016:2878149. doi: 10.1155/2016/2878149. Epub 2016 Aug 14. Can J Gastroenterol Hepatol. 2016. PMID: 27597935 Free PMC article. Review.
Cited by
-
UCN-Centric Prognostic Model for Predicting Overall Survival and Immune Response in Colorectal Cancer.Genes (Basel). 2024 Aug 29;15(9):1139. doi: 10.3390/genes15091139. Genes (Basel). 2024. PMID: 39336730 Free PMC article.
-
Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.Front Oncol. 2024 Jul 29;14:1407008. doi: 10.3389/fonc.2024.1407008. eCollection 2024. Front Oncol. 2024. PMID: 39135996 Free PMC article. Review.
-
Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis.Infect Agent Cancer. 2024 Aug 10;19(1):37. doi: 10.1186/s13027-024-00602-6. Infect Agent Cancer. 2024. PMID: 39123209 Free PMC article.
-
Effectiveness of colonoscopy, immune fecal occult blood testing, and risk-graded screening strategies in colorectal cancer screening.World J Gastrointest Surg. 2024 Jul 27;16(7):2270-2280. doi: 10.4240/wjgs.v16.i7.2270. World J Gastrointest Surg. 2024. PMID: 39087098 Free PMC article.
-
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trial.Res Sq [Preprint]. 2024 Jul 18:rs.3.rs-4558718. doi: 10.21203/rs.3.rs-4558718/v1. Res Sq. 2024. PMID: 39070625 Free PMC article. Preprint.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917 - PubMed
-
- U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–637 - PubMed
-
- The Underserved and Health Information Technology: Issues and Opportunities http://aspe.hhs.gov/sp/reports/2009/underserved/report.html Accessed February 27, 2014
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
